3-51959291-A-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001174100.2(PCBP4):āc.638T>Gā(p.Val213Gly) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.0000266 in 1,613,910 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001174100.2 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PCBP4 | NM_001174100.2 | c.638T>G | p.Val213Gly | missense_variant, splice_region_variant | 11/14 | ENST00000461554.6 | NP_001167571.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PCBP4 | ENST00000461554.6 | c.638T>G | p.Val213Gly | missense_variant, splice_region_variant | 11/14 | 1 | NM_001174100.2 | ENSP00000417196 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000184 AC: 28AN: 152064Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000279 AC: 7AN: 250486Hom.: 0 AF XY: 0.0000443 AC XY: 6AN XY: 135448
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1461728Hom.: 0 Cov.: 32 AF XY: 0.00000963 AC XY: 7AN XY: 727168
GnomAD4 genome AF: 0.000184 AC: 28AN: 152182Hom.: 0 Cov.: 32 AF XY: 0.000228 AC XY: 17AN XY: 74410
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 19, 2024 | The c.638T>G (p.V213G) alteration is located in exon 11 (coding exon 9) of the PCBP4 gene. This alteration results from a T to G substitution at nucleotide position 638, causing the valine (V) at amino acid position 213 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at